Cart
0

Close

Upcoming Allied Market Research
2023
Ubiquitin Proteasome Market

Ubiquitin Proteasome Market

by Application (Scientific Research and Cancer Treatment) - Global Opportunity Analysis and Industry Forecast, 2021-2031

LS : Pharmaceuticals
Report Code: A03877
Pages: NA
Mar 2023 | 5092 Views
Author(s) : NA
Tables: NA
Charts: NA

  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Ubiquitin Proteasome Market

Request Now !

Proteasomes are cellular complexes responsible for protein breakdown. Ubiquitin is a small protein found in all cellular tissues in humans and other eukaryotic organisms that support to regulate the processes of other proteins. Ubiquitin proteasome is a highly regulated mechanism of intracellular protein degradation, by marking proteins that are linked to ubiquitin.

The systems play a vital role in biological functions of the body such as antigen presentation, regulation of gene transcription & the cell cycle, and activation of NF-KB, which is responsible to regulate the immunological response to infections.

The development of ubiquitin proteasomes for treatment of cancer such as multiple myeloma and mantle cell lymphoma majorly drives the market. Increase in use of Ubiquitin Proteasome as a research tool in academic and industrial research center fuels the market growth. In addition, the patent expiry of Velcade (brand name of Ubiquitin Proteasome by Takeda Pharmaceutical Company Ltd) in Nov 2017 is anticipated to boost the market.

However, high cost of the drug and stringent government regulations involved in the production of Ubiquitin Proteasome hinder the growth of the market. In addition, side effects associated with ubiquitin proteasome such as low blood pressure, peripheral neuropathy, heart problems, lung problems, GIT problems, and others also restrain the market. Ongoing R&D activities related to Ubiquitin Proteasome are anticipated to present new opportunities for the market.

The market is segmented on the basis of application and region. Based on application, the market is bifurcated into scientific research and cancer treatment. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

  • The study provides an in-depth analysis of the global ubiquitin proteasome market with current trends and future estimations to elucidate the investment pockets.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  • The report provides a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis of different segments facilitates to understand various products of the market.
  • Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.

Ubiquitin Proteasome Market Key Segments:

By Application

  • Scientific Research
  • Cancer Treatment
    • Multiple Myeloma (A Cancer of the Plasma Cells)
    • Mantle Cell Lymphoma (A Cancer of the Lymph Nodes)

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa

List of players profiled in the report

  • Takeda Pharmaceutical Company Ltd
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd
  • Novelix Pharmaceuticals, Inc
  • GlaxoSmithKline Pharmaceuticals Ltd
  • Onyx Pharmaceuticals, Inc
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Novartis International AG
  • Glenmark Pharmaceuticals Ltd

 Ubiquitin Proteasome Market Report Highlights

Aspects Details
By Application
  • Scientific Research
  • Cancer Treatment
    • Multiple Myeloma
    • Mantle Cell Lymphoma
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Takeda Pharmaceutical Company Ltd, Johnson and Johnson, F. Hoffmann La Roche Ltd, Novelix Pharmaceuticals, Inc, GlaxoSmithKline Pharmaceuticals Ltd, Onyx Pharmaceuticals, Inc, Teva Pharmaceutical Industries Ltd., Mylan N.V., Novartis International AG, Glenmark Pharmaceuticals Ltd
 

Loading Table Of Content...


 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Ubiquitin Proteasome Market

Start reading.
This Report and over 19,654+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers